These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2572276

  • 1. Further characterization of the binding of plasminogen to heparin: evidence for the involvement of lysine residues.
    Soeda S, Ohki H, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1989 Nov 09; 999(1):29-35. PubMed ID: 2572276
    [Abstract] [Full Text] [Related]

  • 2. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E, Thorsen S.
    Biochem J; 1981 Sep 01; 197(3):619-28. PubMed ID: 6459779
    [Abstract] [Full Text] [Related]

  • 3. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775
    [Abstract] [Full Text] [Related]

  • 4. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ, Keegan MC.
    Biochim Biophys Acta; 1985 Aug 08; 830(2):187-94. PubMed ID: 3160389
    [Abstract] [Full Text] [Related]

  • 5. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C, Stüber W, Ehrlich HJ, Pannekoek H, Preissner KT.
    J Biol Chem; 1992 Jun 15; 267(17):12098-105. PubMed ID: 1376317
    [Abstract] [Full Text] [Related]

  • 6. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA, Mangel WF.
    Biochemistry; 1985 Jun 18; 24(13):3279-86. PubMed ID: 3161540
    [Abstract] [Full Text] [Related]

  • 7. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM, Blackburn MN.
    J Biol Chem; 1984 Jan 25; 259(2):935-8. PubMed ID: 6420409
    [Abstract] [Full Text] [Related]

  • 8. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B, Rojas G, Vranckx R, Lijnen HR, Anglés-Cano E.
    FEBS J; 2005 Jul 25; 272(13):3387-400. PubMed ID: 15978044
    [Abstract] [Full Text] [Related]

  • 9. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH, Summaria L, Robbins KC.
    Biochemistry; 1984 May 22; 23(11):2384-7. PubMed ID: 6236844
    [Abstract] [Full Text] [Related]

  • 10. Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.
    Summaria L, Robbins KC.
    J Biol Chem; 1976 Sep 25; 251(18):5810-13. PubMed ID: 134997
    [Abstract] [Full Text] [Related]

  • 11. The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.
    Gerber SS, Lejon S, Locher M, Schaller J.
    Cell Mol Life Sci; 2010 May 25; 67(9):1505-18. PubMed ID: 20112045
    [Abstract] [Full Text] [Related]

  • 12. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B, Lijnen HR, Collen D.
    Biochim Biophys Acta; 1979 Jul 25; 579(1):142-54. PubMed ID: 157166
    [Abstract] [Full Text] [Related]

  • 13. Role of the kringle domain in plasminogen activation with staphylokinase.
    Arai K, Madoiwa S, Mimuro J, Asakura S, Matsuda M, Sako T, Sakata Y.
    J Biochem; 1998 Jan 25; 123(1):71-7. PubMed ID: 9504411
    [Abstract] [Full Text] [Related]

  • 14. Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen.
    DePoli P, Bacon-Baguley T, Kendra-Franczak S, Cederholm MT, Walz DA.
    Blood; 1989 Mar 25; 73(4):976-82. PubMed ID: 2522013
    [Abstract] [Full Text] [Related]

  • 15. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
    Church FC, Pratt CW, Noyes CM, Kalayanamit T, Sherrill GB, Tobin RB, Meade JB.
    J Biol Chem; 1989 Nov 05; 264(31):18419-25. PubMed ID: 2509458
    [Abstract] [Full Text] [Related]

  • 16. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.
    Lo SK, Ryan TJ, Gilboa N, Lai L, Malik AB.
    J Clin Invest; 1989 Sep 05; 84(3):793-801. PubMed ID: 2569479
    [Abstract] [Full Text] [Related]

  • 17. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
    Miles LA, Plow EF.
    Biochemistry; 1986 Nov 04; 25(22):6926-33. PubMed ID: 3099830
    [Abstract] [Full Text] [Related]

  • 18. The effect of heparin on the affinity chromatography of plasminogen. Demonstration of heparin-plasminogen interaction.
    Hatton MW, Regoeczi E.
    Biochim Biophys Acta; 1975 Apr 29; 386(2):451-60. PubMed ID: 1138880
    [Abstract] [Full Text] [Related]

  • 19. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC, Suenson E.
    Biochim Biophys Acta; 1986 Sep 04; 883(2):313-25. PubMed ID: 2943320
    [Abstract] [Full Text] [Related]

  • 20. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML.
    Biochemistry; 1997 Aug 26; 36(34):10353-63. PubMed ID: 9265615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.